Reference-Feb-22-A5
- Tomeh, M. A., Hadianamrei, R., & Zhao, X. (2019). A Review of Curcumin and Its Derivatives as Anticancer Agents. International journal of molecular sciences, 20(5), 1033. https://doi.org/10.3390/ijms20051033
- Baldi, A., De Luca, A., Maiorano, P., D’Angelo, C., & Giordano, A. (2020). Curcumin as an Anticancer Agent in Malignant Mesothelioma: A Review. International Journal of Molecular Sciences, 21(5), 1839. MDPI AG. Retrieved from http://dx.doi.org/10.3390/ijms21051839
- Pongrakananon, Varisa & Rojanasakul, Yon., Advances in Cancer Therapy, (2011). Anticancer Properties of Curcumin. 10.5772/23594.
- Mansouri, K., Rasoulpoor, S., Daneshkhah, A. et al. (2020), Clinical effects of curcumin in enhancing cancer therapy: A systematic review. BMC Cancer 20, 791. https://doi.org/10.1186/s12885-020-07256-8
- Kunnumakkara, A. B., Bordoloi, D., Padmavathi, G., Monisha, J., Roy, N. K., Prasad, S., & Aggarwal, B. B. (2017). Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. British journal of pharmacology, 174(11), 1325–1348. https://doi.org/10.1111/bph.13621
